or Try an Advanced Search...

    Technical Analysis for BCDA - BioCardia, Inc.

    Grade Last Price % Change Price Change
    F 0.38 2.34% 0.01
    BCDA closed up 2.34 percent on Friday, April 26, 2024, on 8 percent of normal volume.
    Earnings due: May 8
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical BCDA trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Bollinger Band Squeeze Range Contraction 2.34%
    BB Squeeze Started Range Contraction 2.34%
    Inside Day Range Contraction 2.34%
    Gapped Down Weakness 2.34%
    Up 3 Days in a Row Strength -0.76%
    MACD Bullish Signal Line Cross Bullish 0.16%
    Hammer Candlestick Bullish 2.39%
    Older End-of-Day Signals for BCDA ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 17 hours ago
    60 Minute Opening Range Breakdown about 18 hours ago
    10 DMA Resistance about 18 hours ago
    20 DMA Resistance about 19 hours ago
    Up 3% about 19 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BCDA Chart by TradingView
    Basic chart:

    Profile

    BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia. The company is also developing CardiALLO Cell Therapy System, an investigational culture expanded bone marrow derived from mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system; and Morph vascular access product line, which provides catheter products. BioCardia, Inc. is based in San Carlos, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Bone Stem Cell Cell Therapy Catheter Cardiovascular Disease Heart Failure Vascular Disease Regenerative Medicine Heart Disease Vascular Access Products Bone Marrow Aging Associated Diseases Ischemia Treatment Of Heart Failure

    Is BCDA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
    Apr 2 Insiders Are Buying These 11 Penny Stocks
    Apr 1 BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript
    Mar 29 BioCardia Full Year 2023 Earnings: Misses Expectations
    Mar 28 Q4 2023 BioCardia Inc Earnings Call
    Mar 28 BioCardia, Inc. (BCDA) Q4 2023 Earnings Call Transcript
    Mar 27 BioCardia GAAP EPS of -$0.55 misses by $0.09, revenue of $0.5M misses by $0.2M
    Mar 27 BioCardia: Q4 Earnings Insights
    Mar 27 BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
    Mar 27 Earnings Scheduled For March 27, 2024
    See more BCDA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.9199
    52 Week Low 0.32
    Average Volume 361,748
    200-Day Moving Average 0.61
    50-Day Moving Average 0.41
    20-Day Moving Average 0.38
    10-Day Moving Average 0.37
    Average True Range 0.02
    RSI (14) 46.24
    ADX 15.08
    +DI 15.78
    -DI 21.55
    Chandelier Exit (Long, 3 ATRs) 0.35
    Chandelier Exit (Short, 3 ATRs) 0.39
    Upper Bollinger Bands 0.40
    Lower Bollinger Band 0.36
    Percent B (%b) 0.4
    BandWidth 12.28
    MACD Line -0.01
    MACD Signal Line -0.01
    MACD Histogram 0.0018
    Fundamentals Value
    Market Cap 8.9 Million
    Num Shares 23.6 Million
    EPS -0.62
    Price-to-Earnings (P/E) Ratio -0.61
    Price-to-Sales 17.62
    Price-to-Book 10.67
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.40
    Resistance 3 (R3) 0.40 0.39 0.40
    Resistance 2 (R2) 0.39 0.39 0.39 0.39
    Resistance 1 (R1) 0.38 0.38 0.38 0.38 0.39
    Pivot Point 0.38 0.38 0.37 0.38 0.38
    Support 1 (S1) 0.37 0.37 0.37 0.37 0.36
    Support 2 (S2) 0.36 0.37 0.36 0.36
    Support 3 (S3) 0.35 0.36 0.36
    Support 4 (S4) 0.35